The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Preventable Vaccines Market Research Report 2025
Synopsis
The global Preventable Vaccines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Preventable Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Preventable Vaccines.
Report Scope
The Preventable Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Preventable Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Preventable Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Merck
Novartis
Pfizer
Sanofi
Takeda Pharmaceutical
Abbott
Roche
AstraZeneca
Mitsubishi Tanabe Pharma
Lupin
Serum Institute of India
LG Life Sciences
S K Chemicals
Shenzhen Kangtai Biological Products
Sinovac Biotech
Janssen Pharmaceuticals
Crucell
Bavarian Nordic
Baxter
Bharat Biotech
Dynavax
Bausch Health
Protein Sciences
Panacea Biotec
Segment by Type
Adult Preventable Vaccines
Pediatric Preventable Vaccines
Segment by Application
Bacterial Diseases
Virus Diseases
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Preventable Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Preventable Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Preventable Vaccines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Preventable Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Preventable Vaccines.
Report Scope
The Preventable Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Preventable Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Preventable Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Merck
Novartis
Pfizer
Sanofi
Takeda Pharmaceutical
Abbott
Roche
AstraZeneca
Mitsubishi Tanabe Pharma
Lupin
Serum Institute of India
LG Life Sciences
S K Chemicals
Shenzhen Kangtai Biological Products
Sinovac Biotech
Janssen Pharmaceuticals
Crucell
Bavarian Nordic
Baxter
Bharat Biotech
Dynavax
Bausch Health
Protein Sciences
Panacea Biotec
Segment by Type
Adult Preventable Vaccines
Pediatric Preventable Vaccines
Segment by Application
Bacterial Diseases
Virus Diseases
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Preventable Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Preventable Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Preventable Vaccines Market Overview
1.1 Product Overview and Scope of Preventable Vaccines
1.2 Preventable Vaccines Segment by Type
1.2.1 Global Preventable Vaccines Market Value Comparison by Type (2024-2030)
1.2.2 Adult Preventable Vaccines
1.2.3 Pediatric Preventable Vaccines
1.3 Preventable Vaccines Segment by Application
1.3.1 Global Preventable Vaccines Market Value by Application: (2024-2030)
1.3.2 Bacterial Diseases
1.3.3 Virus Diseases
1.4 Global Preventable Vaccines Market Size Estimates and Forecasts
1.4.1 Global Preventable Vaccines Revenue 2019-2030
1.4.2 Global Preventable Vaccines Sales 2019-2030
1.4.3 Global Preventable Vaccines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Preventable Vaccines Market Competition by Manufacturers
2.1 Global Preventable Vaccines Sales Market Share by Manufacturers (2019-2024)
2.2 Global Preventable Vaccines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Preventable Vaccines Average Price by Manufacturers (2019-2024)
2.4 Global Preventable Vaccines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Preventable Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Preventable Vaccines, Product Type & Application
2.7 Preventable Vaccines Market Competitive Situation and Trends
2.7.1 Preventable Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Preventable Vaccines Players Market Share by Revenue
2.7.3 Global Preventable Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Preventable Vaccines Retrospective Market Scenario by Region
3.1 Global Preventable Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Preventable Vaccines Global Preventable Vaccines Sales by Region: 2019-2030
3.2.1 Global Preventable Vaccines Sales by Region: 2019-2024
3.2.2 Global Preventable Vaccines Sales by Region: 2025-2030
3.3 Global Preventable Vaccines Global Preventable Vaccines Revenue by Region: 2019-2030
3.3.1 Global Preventable Vaccines Revenue by Region: 2019-2024
3.3.2 Global Preventable Vaccines Revenue by Region: 2025-2030
3.4 North America Preventable Vaccines Market Facts & Figures by Country
3.4.1 North America Preventable Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Preventable Vaccines Sales by Country (2019-2030)
3.4.3 North America Preventable Vaccines Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Preventable Vaccines Market Facts & Figures by Country
3.5.1 Europe Preventable Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Preventable Vaccines Sales by Country (2019-2030)
3.5.3 Europe Preventable Vaccines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Preventable Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Preventable Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Preventable Vaccines Sales by Country (2019-2030)
3.6.3 Asia Pacific Preventable Vaccines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Preventable Vaccines Market Facts & Figures by Country
3.7.1 Latin America Preventable Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Preventable Vaccines Sales by Country (2019-2030)
3.7.3 Latin America Preventable Vaccines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Preventable Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Preventable Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Preventable Vaccines Sales by Country (2019-2030)
3.8.3 Middle East and Africa Preventable Vaccines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Preventable Vaccines Sales by Type (2019-2030)
4.1.1 Global Preventable Vaccines Sales by Type (2019-2024)
4.1.2 Global Preventable Vaccines Sales by Type (2025-2030)
4.1.3 Global Preventable Vaccines Sales Market Share by Type (2019-2030)
4.2 Global Preventable Vaccines Revenue by Type (2019-2030)
4.2.1 Global Preventable Vaccines Revenue by Type (2019-2024)
4.2.2 Global Preventable Vaccines Revenue by Type (2025-2030)
4.2.3 Global Preventable Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global Preventable Vaccines Price by Type (2019-2030)
5 Segment by Application
5.1 Global Preventable Vaccines Sales by Application (2019-2030)
5.1.1 Global Preventable Vaccines Sales by Application (2019-2024)
5.1.2 Global Preventable Vaccines Sales by Application (2025-2030)
5.1.3 Global Preventable Vaccines Sales Market Share by Application (2019-2030)
5.2 Global Preventable Vaccines Revenue by Application (2019-2030)
5.2.1 Global Preventable Vaccines Revenue by Application (2019-2024)
5.2.2 Global Preventable Vaccines Revenue by Application (2025-2030)
5.2.3 Global Preventable Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global Preventable Vaccines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Corporation Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Preventable Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GlaxoSmithKline Preventable Vaccines Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Preventable Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck Preventable Vaccines Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Preventable Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Novartis Preventable Vaccines Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Preventable Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer Preventable Vaccines Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Sanofi
6.5.1 Sanofi Corporation Information
6.5.2 Sanofi Description and Business Overview
6.5.3 Sanofi Preventable Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sanofi Preventable Vaccines Product Portfolio
6.5.5 Sanofi Recent Developments/Updates
6.6 Takeda Pharmaceutical
6.6.1 Takeda Pharmaceutical Corporation Information
6.6.2 Takeda Pharmaceutical Description and Business Overview
6.6.3 Takeda Pharmaceutical Preventable Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Takeda Pharmaceutical Preventable Vaccines Product Portfolio
6.6.5 Takeda Pharmaceutical Recent Developments/Updates
6.7 Abbott
6.6.1 Abbott Corporation Information
6.6.2 Abbott Description and Business Overview
6.6.3 Abbott Preventable Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Abbott Preventable Vaccines Product Portfolio
6.7.5 Abbott Recent Developments/Updates
6.8 Roche
6.8.1 Roche Corporation Information
6.8.2 Roche Description and Business Overview
6.8.3 Roche Preventable Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Roche Preventable Vaccines Product Portfolio
6.8.5 Roche Recent Developments/Updates
6.9 AstraZeneca
6.9.1 AstraZeneca Corporation Information
6.9.2 AstraZeneca Description and Business Overview
6.9.3 AstraZeneca Preventable Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.9.4 AstraZeneca Preventable Vaccines Product Portfolio
6.9.5 AstraZeneca Recent Developments/Updates
6.10 Mitsubishi Tanabe Pharma
6.10.1 Mitsubishi Tanabe Pharma Corporation Information
6.10.2 Mitsubishi Tanabe Pharma Description and Business Overview
6.10.3 Mitsubishi Tanabe Pharma Preventable Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Mitsubishi Tanabe Pharma Preventable Vaccines Product Portfolio
6.10.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
6.11 Lupin
6.11.1 Lupin Corporation Information
6.11.2 Lupin Preventable Vaccines Description and Business Overview
6.11.3 Lupin Preventable Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Lupin Preventable Vaccines Product Portfolio
6.11.5 Lupin Recent Developments/Updates
6.12 Serum Institute of India
6.12.1 Serum Institute of India Corporation Information
6.12.2 Serum Institute of India Preventable Vaccines Description and Business Overview
6.12.3 Serum Institute of India Preventable Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Serum Institute of India Preventable Vaccines Product Portfolio
6.12.5 Serum Institute of India Recent Developments/Updates
6.13 LG Life Sciences
6.13.1 LG Life Sciences Corporation Information
6.13.2 LG Life Sciences Preventable Vaccines Description and Business Overview
6.13.3 LG Life Sciences Preventable Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.13.4 LG Life Sciences Preventable Vaccines Product Portfolio
6.13.5 LG Life Sciences Recent Developments/Updates
6.14 S K Chemicals
6.14.1 S K Chemicals Corporation Information
6.14.2 S K Chemicals Preventable Vaccines Description and Business Overview
6.14.3 S K Chemicals Preventable Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.14.4 S K Chemicals Preventable Vaccines Product Portfolio
6.14.5 S K Chemicals Recent Developments/Updates
6.15 Shenzhen Kangtai Biological Products
6.15.1 Shenzhen Kangtai Biological Products Corporation Information
6.15.2 Shenzhen Kangtai Biological Products Preventable Vaccines Description and Business Overview
6.15.3 Shenzhen Kangtai Biological Products Preventable Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Shenzhen Kangtai Biological Products Preventable Vaccines Product Portfolio
6.15.5 Shenzhen Kangtai Biological Products Recent Developments/Updates
6.16 Sinovac Biotech
6.16.1 Sinovac Biotech Corporation Information
6.16.2 Sinovac Biotech Preventable Vaccines Description and Business Overview
6.16.3 Sinovac Biotech Preventable Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Sinovac Biotech Preventable Vaccines Product Portfolio
6.16.5 Sinovac Biotech Recent Developments/Updates
6.17 Janssen Pharmaceuticals
6.17.1 Janssen Pharmaceuticals Corporation Information
6.17.2 Janssen Pharmaceuticals Preventable Vaccines Description and Business Overview
6.17.3 Janssen Pharmaceuticals Preventable Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Janssen Pharmaceuticals Preventable Vaccines Product Portfolio
6.17.5 Janssen Pharmaceuticals Recent Developments/Updates
6.18 Crucell
6.18.1 Crucell Corporation Information
6.18.2 Crucell Preventable Vaccines Description and Business Overview
6.18.3 Crucell Preventable Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Crucell Preventable Vaccines Product Portfolio
6.18.5 Crucell Recent Developments/Updates
6.19 Bavarian Nordic
6.19.1 Bavarian Nordic Corporation Information
6.19.2 Bavarian Nordic Preventable Vaccines Description and Business Overview
6.19.3 Bavarian Nordic Preventable Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Bavarian Nordic Preventable Vaccines Product Portfolio
6.19.5 Bavarian Nordic Recent Developments/Updates
6.20 Baxter
6.20.1 Baxter Corporation Information
6.20.2 Baxter Preventable Vaccines Description and Business Overview
6.20.3 Baxter Preventable Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Baxter Preventable Vaccines Product Portfolio
6.20.5 Baxter Recent Developments/Updates
6.21 Bharat Biotech
6.21.1 Bharat Biotech Corporation Information
6.21.2 Bharat Biotech Preventable Vaccines Description and Business Overview
6.21.3 Bharat Biotech Preventable Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Bharat Biotech Preventable Vaccines Product Portfolio
6.21.5 Bharat Biotech Recent Developments/Updates
6.22 Dynavax
6.22.1 Dynavax Corporation Information
6.22.2 Dynavax Preventable Vaccines Description and Business Overview
6.22.3 Dynavax Preventable Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.22.4 Dynavax Preventable Vaccines Product Portfolio
6.22.5 Dynavax Recent Developments/Updates
6.23 Bausch Health
6.23.1 Bausch Health Corporation Information
6.23.2 Bausch Health Preventable Vaccines Description and Business Overview
6.23.3 Bausch Health Preventable Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.23.4 Bausch Health Preventable Vaccines Product Portfolio
6.23.5 Bausch Health Recent Developments/Updates
6.24 Protein Sciences
6.24.1 Protein Sciences Corporation Information
6.24.2 Protein Sciences Preventable Vaccines Description and Business Overview
6.24.3 Protein Sciences Preventable Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.24.4 Protein Sciences Preventable Vaccines Product Portfolio
6.24.5 Protein Sciences Recent Developments/Updates
6.25 Panacea Biotec
6.25.1 Panacea Biotec Corporation Information
6.25.2 Panacea Biotec Preventable Vaccines Description and Business Overview
6.25.3 Panacea Biotec Preventable Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.25.4 Panacea Biotec Preventable Vaccines Product Portfolio
6.25.5 Panacea Biotec Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Preventable Vaccines Industry Chain Analysis
7.2 Preventable Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Preventable Vaccines Production Mode & Process
7.4 Preventable Vaccines Sales and Marketing
7.4.1 Preventable Vaccines Sales Channels
7.4.2 Preventable Vaccines Distributors
7.5 Preventable Vaccines Customers
8 Preventable Vaccines Market Dynamics
8.1 Preventable Vaccines Industry Trends
8.2 Preventable Vaccines Market Drivers
8.3 Preventable Vaccines Market Challenges
8.4 Preventable Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Preventable Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Preventable Vaccines Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Preventable Vaccines Market Competitive Situation by Manufacturers in 2023
Table 4. Global Preventable Vaccines Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Preventable Vaccines Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Preventable Vaccines Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Preventable Vaccines Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Preventable Vaccines Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Preventable Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Preventable Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Preventable Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Preventable Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Preventable Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preventable Vaccines as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Preventable Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Preventable Vaccines Sales by Region (2019-2024) & (K Units)
Table 18. Global Preventable Vaccines Sales Market Share by Region (2019-2024)
Table 19. Global Preventable Vaccines Sales by Region (2025-2030) & (K Units)
Table 20. Global Preventable Vaccines Sales Market Share by Region (2025-2030)
Table 21. Global Preventable Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Preventable Vaccines Revenue Market Share by Region (2019-2024)
Table 23. Global Preventable Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Preventable Vaccines Revenue Market Share by Region (2025-2030)
Table 25. North America Preventable Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Preventable Vaccines Sales by Country (2019-2024) & (K Units)
Table 27. North America Preventable Vaccines Sales by Country (2025-2030) & (K Units)
Table 28. North America Preventable Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Preventable Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Preventable Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Preventable Vaccines Sales by Country (2019-2024) & (K Units)
Table 32. Europe Preventable Vaccines Sales by Country (2025-2030) & (K Units)
Table 33. Europe Preventable Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Preventable Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Preventable Vaccines Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Preventable Vaccines Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Preventable Vaccines Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Preventable Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Preventable Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Preventable Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Preventable Vaccines Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Preventable Vaccines Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Preventable Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Preventable Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Preventable Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Preventable Vaccines Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Preventable Vaccines Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Preventable Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Preventable Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Preventable Vaccines Sales (K Units) by Type (2019-2024)
Table 51. Global Preventable Vaccines Sales (K Units) by Type (2025-2030)
Table 52. Global Preventable Vaccines Sales Market Share by Type (2019-2024)
Table 53. Global Preventable Vaccines Sales Market Share by Type (2025-2030)
Table 54. Global Preventable Vaccines Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Preventable Vaccines Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Preventable Vaccines Revenue Market Share by Type (2019-2024)
Table 57. Global Preventable Vaccines Revenue Market Share by Type (2025-2030)
Table 58. Global Preventable Vaccines Price (USD/Unit) by Type (2019-2024)
Table 59. Global Preventable Vaccines Price (USD/Unit) by Type (2025-2030)
Table 60. Global Preventable Vaccines Sales (K Units) by Application (2019-2024)
Table 61. Global Preventable Vaccines Sales (K Units) by Application (2025-2030)
Table 62. Global Preventable Vaccines Sales Market Share by Application (2019-2024)
Table 63. Global Preventable Vaccines Sales Market Share by Application (2025-2030)
Table 64. Global Preventable Vaccines Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Preventable Vaccines Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Preventable Vaccines Revenue Market Share by Application (2019-2024)
Table 67. Global Preventable Vaccines Revenue Market Share by Application (2025-2030)
Table 68. Global Preventable Vaccines Price (USD/Unit) by Application (2019-2024)
Table 69. Global Preventable Vaccines Price (USD/Unit) by Application (2025-2030)
Table 70. GlaxoSmithKline Corporation Information
Table 71. GlaxoSmithKline Description and Business Overview
Table 72. GlaxoSmithKline Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. GlaxoSmithKline Preventable Vaccines Product
Table 74. GlaxoSmithKline Recent Developments/Updates
Table 75. Merck Corporation Information
Table 76. Merck Description and Business Overview
Table 77. Merck Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Merck Preventable Vaccines Product
Table 79. Merck Recent Developments/Updates
Table 80. Novartis Corporation Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Novartis Preventable Vaccines Product
Table 84. Novartis Recent Developments/Updates
Table 85. Pfizer Corporation Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Pfizer Preventable Vaccines Product
Table 89. Pfizer Recent Developments/Updates
Table 90. Sanofi Corporation Information
Table 91. Sanofi Description and Business Overview
Table 92. Sanofi Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Sanofi Preventable Vaccines Product
Table 94. Sanofi Recent Developments/Updates
Table 95. Takeda Pharmaceutical Corporation Information
Table 96. Takeda Pharmaceutical Description and Business Overview
Table 97. Takeda Pharmaceutical Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Takeda Pharmaceutical Preventable Vaccines Product
Table 99. Takeda Pharmaceutical Recent Developments/Updates
Table 100. Abbott Corporation Information
Table 101. Abbott Description and Business Overview
Table 102. Abbott Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Abbott Preventable Vaccines Product
Table 104. Abbott Recent Developments/Updates
Table 105. Roche Corporation Information
Table 106. Roche Description and Business Overview
Table 107. Roche Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Roche Preventable Vaccines Product
Table 109. Roche Recent Developments/Updates
Table 110. AstraZeneca Corporation Information
Table 111. AstraZeneca Description and Business Overview
Table 112. AstraZeneca Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. AstraZeneca Preventable Vaccines Product
Table 114. AstraZeneca Recent Developments/Updates
Table 115. Mitsubishi Tanabe Pharma Corporation Information
Table 116. Mitsubishi Tanabe Pharma Description and Business Overview
Table 117. Mitsubishi Tanabe Pharma Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Mitsubishi Tanabe Pharma Preventable Vaccines Product
Table 119. Mitsubishi Tanabe Pharma Recent Developments/Updates
Table 120. Lupin Corporation Information
Table 121. Lupin Description and Business Overview
Table 122. Lupin Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. Lupin Preventable Vaccines Product
Table 124. Lupin Recent Developments/Updates
Table 125. Serum Institute of India Corporation Information
Table 126. Serum Institute of India Description and Business Overview
Table 127. Serum Institute of India Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. Serum Institute of India Preventable Vaccines Product
Table 129. Serum Institute of India Recent Developments/Updates
Table 130. LG Life Sciences Corporation Information
Table 131. LG Life Sciences Description and Business Overview
Table 132. LG Life Sciences Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. LG Life Sciences Preventable Vaccines Product
Table 134. LG Life Sciences Recent Developments/Updates
Table 135. S K Chemicals Corporation Information
Table 136. S K Chemicals Description and Business Overview
Table 137. S K Chemicals Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 138. S K Chemicals Preventable Vaccines Product
Table 139. S K Chemicals Recent Developments/Updates
Table 140. Shenzhen Kangtai Biological Products Corporation Information
Table 141. Shenzhen Kangtai Biological Products Description and Business Overview
Table 142. Shenzhen Kangtai Biological Products Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 143. Shenzhen Kangtai Biological Products Preventable Vaccines Product
Table 144. Shenzhen Kangtai Biological Products Recent Developments/Updates
Table 145. Sinovac Biotech Corporation Information
Table 146. Sinovac Biotech Description and Business Overview
Table 147. Sinovac Biotech Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 148. Sinovac Biotech Preventable Vaccines Product
Table 149. Sinovac Biotech Recent Developments/Updates
Table 150. Janssen Pharmaceuticals Corporation Information
Table 151. Janssen Pharmaceuticals Description and Business Overview
Table 152. Janssen Pharmaceuticals Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 153. Janssen Pharmaceuticals Preventable Vaccines Product
Table 154. Janssen Pharmaceuticals Recent Developments/Updates
Table 155. Crucell Corporation Information
Table 156. Crucell Description and Business Overview
Table 157. Crucell Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 158. Crucell Preventable Vaccines Product
Table 159. Crucell Recent Developments/Updates
Table 160. Bavarian Nordic Corporation Information
Table 161. Bavarian Nordic Description and Business Overview
Table 162. Bavarian Nordic Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 163. Bavarian Nordic Preventable Vaccines Product
Table 164. Bavarian Nordic Recent Developments/Updates
Table 165. Baxter Corporation Information
Table 166. Baxter Description and Business Overview
Table 167. Baxter Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 168. Baxter Preventable Vaccines Product
Table 169. Baxter Recent Developments/Updates
Table 170. Bharat Biotech Corporation Information
Table 171. Bharat Biotech Description and Business Overview
Table 172. Bharat Biotech Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 173. Bharat Biotech Preventable Vaccines Product
Table 174. Bharat Biotech Recent Developments/Updates
Table 175. Dynavax Corporation Information
Table 176. Dynavax Description and Business Overview
Table 177. Dynavax Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 178. Dynavax Preventable Vaccines Product
Table 179. Dynavax Recent Developments/Updates
Table 180. Bausch Health Corporation Information
Table 181. Bausch Health Description and Business Overview
Table 182. Bausch Health Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 183. Bausch Health Preventable Vaccines Product
Table 184. Bausch Health Recent Developments/Updates
Table 185. Protein Sciences Corporation Information
Table 186. Protein Sciences Description and Business Overview
Table 187. Protein Sciences Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 188. Protein Sciences Preventable Vaccines Product
Table 189. Protein Sciences Recent Developments/Updates
Table 190. Panacea Biotec Corporation Information
Table 191. Panacea Biotec Description and Business Overview
Table 192. Panacea Biotec Preventable Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 193. Panacea Biotec Preventable Vaccines Product
Table 194. Panacea Biotec Recent Developments/Updates
Table 195. Key Raw Materials Lists
Table 196. Raw Materials Key Suppliers Lists
Table 197. Preventable Vaccines Distributors List
Table 198. Preventable Vaccines Customers List
Table 199. Preventable Vaccines Market Trends
Table 200. Preventable Vaccines Market Drivers
Table 201. Preventable Vaccines Market Challenges
Table 202. Preventable Vaccines Market Restraints
Table 203. Research Programs/Design for This Report
Table 204. Key Data Information from Secondary Sources
Table 205. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Preventable Vaccines
Figure 2. Global Preventable Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Preventable Vaccines Market Share by Type in 2023 & 2030
Figure 4. Adult Preventable Vaccines Product Picture
Figure 5. Pediatric Preventable Vaccines Product Picture
Figure 6. Global Preventable Vaccines Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Preventable Vaccines Market Share by Application in 2023 & 2030
Figure 8. Bacterial Diseases
Figure 9. Virus Diseases
Figure 10. Global Preventable Vaccines Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Preventable Vaccines Market Size (2019-2030) & (US$ Million)
Figure 12. Global Preventable Vaccines Sales (2019-2030) & (K Units)
Figure 13. Global Preventable Vaccines Average Price (USD/Unit) & (2019-2030)
Figure 14. Preventable Vaccines Report Years Considered
Figure 15. Preventable Vaccines Sales Share by Manufacturers in 2023
Figure 16. Global Preventable Vaccines Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Preventable Vaccines Players: Market Share by Revenue in 2023
Figure 18. Preventable Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Preventable Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Preventable Vaccines Sales Market Share by Country (2019-2030)
Figure 21. North America Preventable Vaccines Revenue Market Share by Country (2019-2030)
Figure 22. U.S. Preventable Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Preventable Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Preventable Vaccines Sales Market Share by Country (2019-2030)
Figure 25. Europe Preventable Vaccines Revenue Market Share by Country (2019-2030)
Figure 26. Germany Preventable Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Preventable Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Preventable Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Preventable Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Preventable Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Preventable Vaccines Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Preventable Vaccines Revenue Market Share by Region (2019-2030)
Figure 33. China Preventable Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Preventable Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Preventable Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Preventable Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Preventable Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. China Taiwan Preventable Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Preventable Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Preventable Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Preventable Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Preventable Vaccines Sales Market Share by Country (2019-2030)
Figure 43. Latin America Preventable Vaccines Revenue Market Share by Country (2019-2030)
Figure 44. Mexico Preventable Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Brazil Preventable Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Argentina Preventable Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Colombia Preventable Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Preventable Vaccines Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Preventable Vaccines Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Preventable Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Preventable Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Preventable Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Preventable Vaccines by Type (2019-2030)
Figure 54. Global Revenue Market Share of Preventable Vaccines by Type (2019-2030)
Figure 55. Global Preventable Vaccines Price (USD/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Preventable Vaccines by Application (2019-2030)
Figure 57. Global Revenue Market Share of Preventable Vaccines by Application (2019-2030)
Figure 58. Global Preventable Vaccines Price (USD/Unit) by Application (2019-2030)
Figure 59. Preventable Vaccines Value Chain
Figure 60. Preventable Vaccines Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
